Course of Face-to-face Interactions in Adults With Autism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUMC Utrecht
About this trial
This research explores how adults with autism make eye contact during formal and informal interactions; to what extent the nature of a conversation influences how eye contact is made in terms of length, frequency and overall presentation. Also what physiological responses to eye contact are, in order to determine to what extent eye contact leads to an increased, decreased or unchanged stress level. In addition, to gain insight into the similarities and differences in how people with ASD respond to eye contact of others compared to their own eye contact.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Neurotypical adults and adults with an ASD, determined according to an internationally recognized classification system.
Able to understand the instructions.
Motivation to participate in research.
Disqualifiers
No good command of the Dutch language.
Use of alcohol and/or recreational drugs during the research.
Mentally too unstable to participate in the research.
Familiarity with treatment in the VGZ.
Trial design
Design model
Single group
Treatments tested in this trial
Conversation
BehavioralThe design consists of two parts. In the first part, the researcher will have a conversation (with a formal and informal phase, where the subject will be given the idea that only the formal part is part of the study) with an adult with ASD during which covert recordings of the subject's eye behavior will be made, and in addition skin conductance and duration/frequency of eye contact of the subject will be recorded, without the subject knowing that this is intended for the purpose of studying eye contact. In the second part, the researcher and subject will watch the covert recording of the subject's eye behavior, during which the subject's skin conductance will be recorded and details of the subject's behavior as seen by the researcher.
Treatment groups
54 Participants
are divided into 1 treatment groupGroup A: Social interactionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Frequency of eye contact in adults with autism, measured with video, audio and push button.
The research consists of two parts. During the first part, the conversation, the frequency of eye contact will be investigated. This will be measured by video recordings of the eye region combined with the pressing of a push button by the researcher at moments when eye contact is present. Data will be analyzed using software programs Observer XT and Matlab for the integration of push button, video recordings and audio recordings.
Time frame
Baseline2
Duration of eye contact in adults with autism, measured with video, audio and push button.
The research consists of two parts. During the first part, the conversation, the duration of eye contact will be investigated. This will be measured by video recordings of the eye region combined with the pressing of a push button by the researcher at moments when eye contact is present. Data will be analyzed using software programs Observer XT and Matlab for the integration of push button, video recordings and audio recordings.
Time frame
Baseline3
Arousal during eye contact in adults with autism, measured with skin conductance
The research consists of two parts. During the first part, the arousal during eye contact will be investigated. This will be measured by a skin conductance meter and analysed with the software program VSRRP.
Time frame
Baseline4
Arousal during reflection on ones own eye contact in adults with autism, measured with skin conductance
During the second part, the reflection on video recordings of ones own eye contact in aduls with autism, the degree of arousal to seeing their own eye contact will be investigated. For this, skin conductance meter will be used and analysed with the software program VSRRP.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
UMC Utrecht
Lead sponsor
Dimence Groep
Collaborator
Source ClinicalTrials.gov